| scholarly article | Q13442814 |
| P2093 | author name string | Yuan Liu | |
| Ian Crocker | |||
| Walter J Curran | |||
| Roshan S Prabhu | |||
| Hui-Kuo G Shu | |||
| Kirtesh R Patel | |||
| Robert H Press | |||
| Shravan Kandula | |||
| Dana C Nickleach | |||
| P2860 | cites work | Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases | Q48148943 |
| Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial | Q48353715 | ||
| Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control | Q48560105 | ||
| Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial | Q48594003 | ||
| The effectiveness of erlotinib against brain metastases in non-small cell lung cancer patients | Q48628273 | ||
| Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy | Q48933064 | ||
| Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. | Q50711312 | ||
| Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05 | Q73764877 | ||
| Management of brain metastases | Q80890568 | ||
| Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases | Q83366634 | ||
| A clinical nomogram and recursive partitioning analysis to determine the risk of regional failure after radiosurgery alone for brain metastases | Q87131512 | ||
| Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial | Q31065424 | ||
| Concordance for prognostic models with competing risks | Q33762612 | ||
| A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy | Q34061998 | ||
| Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone | Q34498287 | ||
| Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial | Q34551025 | ||
| Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study | Q34679120 | ||
| Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone | Q35742324 | ||
| Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial | Q37187732 | ||
| Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial | Q38406445 | ||
| A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone | Q39390096 | ||
| Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone | Q42697397 | ||
| Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study | Q43522608 | ||
| Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial | Q44442912 | ||
| Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial | Q46388451 | ||
| A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-o | Q46417062 | ||
| Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases | Q48079184 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3836-3843 | |
| P577 | publication date | 2015-08-04 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases | |
| P478 | volume | 121 |
| Q93370865 | Analysis of the drivers of cost of management when patients with brain metastases are treated with upfront radiosurgery |
| Q90575341 | CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgery |
| Q47197834 | External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort |
| Q44596688 | In response to Fogarty et al. and why adjuvant whole brain radiotherapy is not recommended routinely |
| Q41039275 | Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis |
| Q46237859 | Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries |
| Q46175985 | Multi-Institutional Competing Risks Analysis of Distant Brain Failure and Salvage Patterns after Upfront Radiosurgery without Whole Brain Radiotherapy for Brain Metastasis |
| Q93053841 | Predicting intracranial progression following stereotactic radiosurgery for brain metastases: Implications for post SRS imaging |
| Q38614732 | Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram |
| Q59813039 | Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity |
| Q49724523 | Survival and Failure Outcomes Predicted by Brain Metastasis Volumetric Kinetics in Melanoma Patients Following Upfront Treatment with Stereotactic Radiosurgery Alone |
Search more.